Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, USA.
Department of Hematology, St. Jude Children's Research Hospital, TN, USA.
Best Pract Res Clin Haematol. 2021 Jun;34(2):101279. doi: 10.1016/j.beha.2021.101279. Epub 2021 Jun 27.
Inherited bone marrow failure syndromes (IBMFS) are a heterogenous group of diseases caused by pathogenic germline variants in key pathways associated with haematopoiesis and genomic stability. Germline variants in IBMFS-related genes are known to reduce the fitness of hematopoietic stem and progenitor cells (HSPC), which has been hypothesized to drive clonal selection in these diseases. In many IBMFS, somatic mosaicism predominantly impacts cells by two distinct mechanisms, with contrasting effects. An acquired variation can improve cell fitness towards baseline levels, providing rescue of a deleterious phenotype. Alternatively, somatic mosaicism may result in a fitness advantage that results in malignant transformation. This review will describe these phenomena in IBMFS and delineate their relevance for diagnosis and clinical management. In addition, we will discuss which samples and methods can be used for detection of mosaicism according to clinical phenotype, type of mosaicism, and sample availability.
遗传性骨髓衰竭综合征(IBMFS)是一组异质性疾病,由与造血和基因组稳定性相关的关键途径中的致病性种系变异引起。已知 IBMFS 相关基因中的种系变异会降低造血干细胞和祖细胞(HSPC)的适应性,这被假设为这些疾病中克隆选择的驱动因素。在许多 IBMFS 中,体细胞镶嵌主要通过两种不同的机制对细胞产生影响,具有相反的作用。获得性变异可以提高细胞对基线水平的适应性,从而挽救有害表型。或者,体细胞镶嵌可能导致适应性优势,从而导致恶性转化。本综述将描述 IBMFS 中的这些现象,并阐明其对诊断和临床管理的相关性。此外,我们将根据临床表型、镶嵌类型和样本可用性讨论可以用于检测镶嵌的哪些样本和方法。